{"entity":{"type":"insider","cik":"0001494695","url":"/insider/0001494695","json_url":"/insider/0001494695.json","name":"Manning Paul B","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":89,"n_filings":44,"first":"2016-09-15","last":"2026-06-08","span_basis":"filed_date"},"name_variants":[{"name":"Manning Paul B","source":"filing","n_filings":44,"first_seen":"2016-09-15","last_seen":"2026-06-08"}],"transactions":[{"id":5740619,"accession":"0001494695-26-000011","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001494695-26-000011","line_url":"/filing/0001494695-26-000011#line-5","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":88487.0,"shares_display":"88,487","price_per_share":64.28,"price_display":"64.28","price_state":"stated","total_value":5687944.36,"total_display":"5,687,944.36","shares_owned_after":716311.0,"shares_owned_after_display":"716,311","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-04","filed_date":"2026-06-08","scope":"insider"},{"id":5740618,"accession":"0001494695-26-000011","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001494695-26-000011","line_url":"/filing/0001494695-26-000011#line-4","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68265.0,"shares_display":"68,265","price_per_share":63.83,"price_display":"63.83","price_state":"stated","total_value":4357354.95,"total_display":"4,357,354.95","shares_owned_after":810945.0,"shares_owned_after_display":"810,945","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-04","filed_date":"2026-06-08","scope":"insider"},{"id":5740616,"accession":"0001494695-26-000011","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001494695-26-000011","line_url":"/filing/0001494695-26-000011#line-3","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19125.0,"shares_display":"19,125","price_per_share":62.62,"price_display":"62.62","price_state":"stated","total_value":1197607.5,"total_display":"1,197,607.50","shares_owned_after":879210.0,"shares_owned_after_display":"879,210","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-04","filed_date":"2026-06-08","scope":"insider"},{"id":5740614,"accession":"0001494695-26-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001494695-26-000011","line_url":"/filing/0001494695-26-000011#line-2","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12610.0,"shares_display":"12,610","price_per_share":64.42,"price_display":"64.42","price_state":"stated","total_value":812336.2,"total_display":"812,336.20","shares_owned_after":798335.0,"shares_owned_after_display":"798,335","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-04","filed_date":"2026-06-08","scope":"insider"},{"id":5740611,"accession":"0001494695-26-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001494695-26-000011","line_url":"/filing/0001494695-26-000011#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11513.0,"shares_display":"11,513","price_per_share":63.13,"price_display":"63.13","price_state":"stated","total_value":726815.69,"total_display":"726,815.69","shares_owned_after":804798.0,"shares_owned_after_display":"804,798","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-04","filed_date":"2026-06-08","scope":"insider"},{"id":6229062,"accession":"0001193125-26-078246","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-078246","line_url":"/filing/0001193125-26-078246#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":550458.0,"shares_display":"550,458","price_per_share":5.45,"price_display":"5.45","price_state":"stated","total_value":2999996.1,"total_display":"2,999,996.10","shares_owned_after":2763527.0,"shares_owned_after_display":"2,763,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-26","scope":"insider"},{"id":4330926,"accession":"0001494695-25-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001494695-25-000004","line_url":"/filing/0001494695-25-000004#line-2","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2750762.0,"shares_display":"2,750,762","price_per_share":4.2425,"price_display":"4.24","price_state":"stated","total_value":11670107.785,"total_display":"11,670,107.78","shares_owned_after":3348372.0,"shares_owned_after_display":"3,348,372","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-25","scope":"insider"},{"id":4330923,"accession":"0001494695-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001494695-25-000004","line_url":"/filing/0001494695-25-000004#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1375380.0,"shares_display":"1,375,380","price_per_share":4.2425,"price_display":"4.24","price_state":"stated","total_value":5835049.65,"total_display":"5,835,049.65","shares_owned_after":3958189.0,"shares_owned_after_display":"3,958,189","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-25","filed_date":"2025-11-25","scope":"insider"},{"id":4176754,"accession":"0001415889-25-023468","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-25-023468","line_url":"/filing/0001415889-25-023468#line-4","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":254038.0,"shares_display":"254,038","price_per_share":28.67,"price_display":"28.67","price_state":"stated","total_value":7283269.46,"total_display":"7,283,269.46","shares_owned_after":505058.0,"shares_owned_after_display":"505,058","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-02","scope":"insider"},{"id":4176749,"accession":"0001415889-25-023468","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-023468","line_url":"/filing/0001415889-25-023468#line-3","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":74230.0,"shares_display":"74,230","price_per_share":29.14,"price_display":"29.14","price_state":"stated","total_value":2163062.2,"total_display":"2,163,062.20","shares_owned_after":430828.0,"shares_owned_after_display":"430,828","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-02","scope":"insider"},{"id":4176746,"accession":"0001415889-25-023468","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-023468","line_url":"/filing/0001415889-25-023468#line-2","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":188232.0,"shares_display":"188,232","price_per_share":27.62,"price_display":"27.62","price_state":"stated","total_value":5198967.84,"total_display":"5,198,967.84","shares_owned_after":759096.0,"shares_owned_after_display":"759,096","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-29","filed_date":"2025-09-02","scope":"insider"},{"id":4176742,"accession":"0001415889-25-023468","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-023468","line_url":"/filing/0001415889-25-023468#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":154337.0,"shares_display":"154,337","price_per_share":27.94,"price_display":"27.94","price_state":"stated","total_value":4312175.78,"total_display":"4,312,175.78","shares_owned_after":947328.0,"shares_owned_after_display":"947,328","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-28","filed_date":"2025-09-02","scope":"insider"},{"id":4433882,"accession":"0001415889-25-015480","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-015480","line_url":"/filing/0001415889-25-015480#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750000.0,"shares_display":"750,000","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":2062500.0,"total_display":"2,062,500.00","shares_owned_after":2841704.0,"shares_owned_after_display":"2,841,704","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-30","filed_date":"2025-06-03","scope":"insider"},{"id":2181949,"accession":"0000950170-24-137889","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-137889","line_url":"/filing/0000950170-24-137889#line-2","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750000.0,"shares_display":"750,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":4500000.0,"total_display":"4,500,000.00","shares_owned_after":1303752.0,"shares_owned_after_display":"1,303,752","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2024-12-18","scope":"insider"},{"id":2181947,"accession":"0000950170-24-137889","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-137889","line_url":"/filing/0000950170-24-137889#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","shares_owned_after":1142406.0,"shares_owned_after_display":"1,142,406","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2024-12-18","scope":"insider"},{"id":2565573,"accession":"0001415889-24-027709","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-027709","line_url":"/filing/0001415889-24-027709#line-2","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18426966.0,"shares_display":"18,426,966","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":26278094.0,"shares_owned_after_display":"26,278,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-22","filed_date":"2024-11-26","scope":"insider"},{"id":2565569,"accession":"0001415889-24-027709","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-027709","line_url":"/filing/0001415889-24-027709#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4494382.0,"shares_display":"4,494,382","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":5976101.0,"shares_owned_after_display":"5,976,101","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-22","filed_date":"2024-11-26","scope":"insider"},{"id":2035519,"accession":"0001104659-24-100179","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-100179","line_url":"/filing/0001104659-24-100179#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":337078.0,"shares_display":"337,078","price_per_share":8.9,"price_display":"8.90","price_state":"stated","total_value":2999994.2,"total_display":"2,999,994.20","shares_owned_after":816311.0,"shares_owned_after_display":"816,311","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-12","filed_date":"2024-09-16","scope":"insider"},{"id":3086218,"accession":"0001415889-24-018515","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-018515","line_url":"/filing/0001415889-24-018515#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1333333.0,"shares_display":"1,333,333","price_per_share":2.25,"price_display":"2.25","price_state":"stated","total_value":2999999.25,"total_display":"2,999,999.25","shares_owned_after":1333333.0,"shares_owned_after_display":"1,333,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-27","filed_date":"2024-07-01","scope":"insider"},{"id":8430271,"accession":"0001104659-23-126932","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-126932","line_url":"/filing/0001104659-23-126932#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":279330.0,"shares_display":"279,330","price_per_share":7.16,"price_display":"7.16","price_state":"stated","total_value":2000002.8,"total_display":"2,000,002.80","shares_owned_after":279330.0,"shares_owned_after_display":"279,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-14","filed_date":"2023-12-18","scope":"insider"},{"id":8297033,"accession":"0001209191-23-055942","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-055942","line_url":"/filing/0001209191-23-055942#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.63,"price_display":"1.63","price_state":"stated","total_value":163000.0,"total_display":"163,000.00","shares_owned_after":16566667.0,"shares_owned_after_display":"16,566,667","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-17","filed_date":"2023-11-20","scope":"insider"},{"id":8078420,"accession":"0001209191-23-046154","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-046154","line_url":"/filing/0001209191-23-046154#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16466667.0,"shares_display":"16,466,667","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":14820000.3,"total_display":"14,820,000.30","shares_owned_after":16466667.0,"shares_owned_after_display":"16,466,667","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-16","filed_date":"2023-08-16","scope":"insider"},{"id":8501081,"accession":"0001209191-23-043255","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-043255","line_url":"/filing/0001209191-23-043255#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":5.02,"price_display":"5.02","price_state":"stated","total_value":1004000.0,"total_display":"1,004,000.00","shares_owned_after":7851128.0,"shares_owned_after_display":"7,851,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-24","filed_date":"2023-07-24","scope":"insider"},{"id":6632176,"accession":"0001209191-22-055263","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-055263","line_url":"/filing/0001209191-22-055263#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500000.0,"shares_display":"1,500,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","shares_owned_after":1642202.0,"shares_owned_after_display":"1,642,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-31","filed_date":"2022-11-02","scope":"insider"},{"id":6753024,"accession":"0001209191-22-040581","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-040581","line_url":"/filing/0001209191-22-040581#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4761904.0,"shares_display":"4,761,904","price_per_share":2.1,"price_display":"2.10","price_state":"stated","total_value":9999998.4,"total_display":"9,999,998.40","shares_owned_after":13651128.0,"shares_owned_after_display":"13,651,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-05","filed_date":"2022-07-05","scope":"insider"},{"id":6924295,"accession":"0001104659-22-047360","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-047360","line_url":"/filing/0001104659-22-047360#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":392156.0,"shares_display":"392,156","price_per_share":5.1,"price_display":"5.10","price_state":"stated","total_value":1999995.6,"total_display":"1,999,995.60","shares_owned_after":392156.0,"shares_owned_after_display":"392,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-18","filed_date":"2022-04-19","scope":"insider"},{"id":6541697,"accession":"0001209191-22-007126","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-007126","line_url":"/filing/0001209191-22-007126#line-5","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":7.84,"price_display":"7.84","price_state":"stated","total_value":392000.0,"total_display":"392,000.00","shares_owned_after":142202.0,"shares_owned_after_display":"142,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-03","filed_date":"2022-02-04","scope":"insider"},{"id":6541694,"accession":"0001209191-22-007126","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-007126","line_url":"/filing/0001209191-22-007126#line-4","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26602.0,"shares_display":"26,602","price_per_share":7.84,"price_display":"7.84","price_state":"stated","total_value":208559.68,"total_display":"208,559.68","shares_owned_after":2091704.0,"shares_owned_after_display":"2,091,704","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-03","filed_date":"2022-02-04","scope":"insider"},{"id":6541691,"accession":"0001209191-22-007126","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-007126","line_url":"/filing/0001209191-22-007126#line-3","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58000.0,"shares_display":"58,000","price_per_share":7.77,"price_display":"7.77","price_state":"stated","total_value":450660.0,"total_display":"450,660.00","shares_owned_after":92202.0,"shares_owned_after_display":"92,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-02","filed_date":"2022-02-04","scope":"insider"},{"id":6541688,"accession":"0001209191-22-007126","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-007126","line_url":"/filing/0001209191-22-007126#line-2","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45000.0,"shares_display":"45,000","price_per_share":7.77,"price_display":"7.77","price_state":"stated","total_value":349650.0,"total_display":"349,650.00","shares_owned_after":2065102.0,"shares_owned_after_display":"2,065,102","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-02","filed_date":"2022-02-04","scope":"insider"},{"id":6541684,"accession":"0001209191-22-007126","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-007126","line_url":"/filing/0001209191-22-007126#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22000.0,"shares_display":"22,000","price_per_share":7.77,"price_display":"7.77","price_state":"stated","total_value":170940.0,"total_display":"170,940.00","shares_owned_after":22000.0,"shares_owned_after_display":"22,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-02","filed_date":"2022-02-04","scope":"insider"},{"id":5538259,"accession":"0001209191-21-068031","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-068031","line_url":"/filing/0001209191-21-068031#line-2","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19977.0,"shares_display":"19,977","price_per_share":9.22,"price_display":"9.22","price_state":"stated","total_value":184187.94,"total_display":"184,187.94","shares_owned_after":8149394.0,"shares_owned_after_display":"8,149,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-03","filed_date":"2021-12-06","scope":"insider"},{"id":5538254,"accession":"0001209191-21-068031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-068031","line_url":"/filing/0001209191-21-068031#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30023.0,"shares_display":"30,023","price_per_share":9.45,"price_display":"9.45","price_state":"stated","total_value":283717.35,"total_display":"283,717.35","shares_owned_after":8129417.0,"shares_owned_after_display":"8,129,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-06","scope":"insider"},{"id":4678787,"accession":"0001209191-21-067005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-067005","line_url":"/filing/0001209191-21-067005#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2202.0,"shares_display":"2,202","price_per_share":13.19,"price_display":"13.19","price_state":"stated","total_value":29044.38,"total_display":"29,044.38","shares_owned_after":34202.0,"shares_owned_after_display":"34,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-24","filed_date":"2021-11-29","scope":"insider"},{"id":5348345,"accession":"0001209191-21-066702","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-066702","line_url":"/filing/0001209191-21-066702#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":12.54,"price_display":"12.54","price_state":"stated","total_value":250800.0,"total_display":"250,800.00","shares_owned_after":32000.0,"shares_owned_after_display":"32,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-23","filed_date":"2021-11-24","scope":"insider"},{"id":9205004,"accession":"0000899243-21-031614","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-031614","line_url":"/filing/0000899243-21-031614#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1625000.0,"shares_display":"1,625,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":13000000.0,"total_display":"13,000,000.00","shares_owned_after":1681000.0,"shares_owned_after_display":"1,681,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-29","filed_date":"2021-08-04","scope":"insider"},{"id":5037853,"accession":"0000899243-21-030774","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-030774","line_url":"/filing/0000899243-21-030774#line-2","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":7.2972,"price_display":"7.30","price_state":"stated","total_value":145944.0,"total_display":"145,944.00","shares_owned_after":56000.0,"shares_owned_after_display":"56,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-29","filed_date":"2021-07-29","scope":"insider"},{"id":5037849,"accession":"0000899243-21-030774","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-030774","line_url":"/filing/0000899243-21-030774#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":36000.0,"shares_display":"36,000","price_per_share":7.3565,"price_display":"7.36","price_state":"stated","total_value":264834.0,"total_display":"264,834.00","shares_owned_after":36000.0,"shares_owned_after_display":"36,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-27","filed_date":"2021-07-29","scope":"insider"},{"id":4377929,"accession":"0001209191-21-046042","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-046042","line_url":"/filing/0001209191-21-046042#line-3","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Acumen Pharmaceuticals, Inc.","issuer_ticker":"ABOS","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312500.0,"shares_display":"312,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","shares_owned_after":3352693.0,"shares_owned_after_display":"3,352,693","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-06","filed_date":"2021-07-08","scope":"insider"},{"id":4892862,"accession":"0001209191-21-033009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-033009","line_url":"/filing/0001209191-21-033009#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Taysha Gene Therapies, Inc.","issuer_ticker":"TSHA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":20.98,"price_display":"20.98","price_state":"stated","total_value":251760.0,"total_display":"251,760.00","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-14","filed_date":"2021-05-17","scope":"insider"},{"id":5281597,"accession":"0001104659-21-050550","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-050550","line_url":"/filing/0001104659-21-050550#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Liquidia Corp","issuer_ticker":"LQDA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":198413.0,"shares_display":"198,413","price_per_share":2.52,"price_display":"2.52","price_state":"stated","total_value":500000.76,"total_display":"500,000.76","shares_owned_after":737646.0,"shares_owned_after_display":"737,646","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-13","filed_date":"2021-04-15","scope":"insider"},{"id":5147188,"accession":"0001209191-21-023388","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-023388","line_url":"/filing/0001209191-21-023388#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":739830.0,"shares_display":"739,830","price_per_share":14.75,"price_display":"14.75","price_state":"stated","total_value":10912492.5,"total_display":"10,912,492.50","shares_owned_after":739830.0,"shares_owned_after_display":"739,830","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-25","filed_date":"2021-03-29","scope":"insider"},{"id":2443442,"accession":"0001209191-20-047865","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047865","line_url":"/filing/0001209191-20-047865#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":9.09,"price_display":"9.09","price_state":"stated","total_value":181800.0,"total_display":"181,800.00","shares_owned_after":8099394.0,"shares_owned_after_display":"8,099,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-20","filed_date":"2020-08-21","scope":"insider"},{"id":2901577,"accession":"0001209191-20-047409","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047409","line_url":"/filing/0001209191-20-047409#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":8.55,"price_display":"8.55","price_state":"stated","total_value":85500.0,"total_display":"85,500.00","shares_owned_after":1481719.0,"shares_owned_after_display":"1,481,719","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-19","scope":"insider"},{"id":2443317,"accession":"0001209191-20-047100","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047100","line_url":"/filing/0001209191-20-047100#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":6.92,"price_display":"6.92","price_state":"stated","total_value":41520.0,"total_display":"41,520.00","shares_owned_after":1471719.0,"shares_owned_after_display":"1,471,719","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-17","filed_date":"2020-08-18","scope":"insider"},{"id":3017652,"accession":"0001209191-20-046880","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-046880","line_url":"/filing/0001209191-20-046880#line-2","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":6.51,"price_display":"6.51","price_state":"stated","total_value":325500.0,"total_display":"325,500.00","shares_owned_after":1465719.0,"shares_owned_after_display":"1,465,719","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-14","filed_date":"2020-08-17","scope":"insider"},{"id":3017642,"accession":"0001209191-20-046880","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-046880","line_url":"/filing/0001209191-20-046880#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":108500.0,"shares_display":"108,500","price_per_share":6.41,"price_display":"6.41","price_state":"stated","total_value":695485.0,"total_display":"695,485.00","shares_owned_after":1415719.0,"shares_owned_after_display":"1,415,719","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-13","filed_date":"2020-08-17","scope":"insider"},{"id":7872889,"accession":"0001209191-19-052936","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-052936","line_url":"/filing/0001209191-19-052936#line-3","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6900.0,"shares_display":"6,900","price_per_share":15.05,"price_display":"15.05","price_state":"stated","total_value":103845.0,"total_display":"103,845.00","shares_owned_after":8079394.0,"shares_owned_after_display":"8,079,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-10","filed_date":"2019-10-10","scope":"insider"},{"id":7872886,"accession":"0001209191-19-052936","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-052936","line_url":"/filing/0001209191-19-052936#line-2","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8778.0,"shares_display":"8,778","price_per_share":14.06,"price_display":"14.06","price_state":"stated","total_value":123418.68,"total_display":"123,418.68","shares_owned_after":8072494.0,"shares_owned_after_display":"8,072,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-09","filed_date":"2019-10-10","scope":"insider"},{"id":7872883,"accession":"0001209191-19-052936","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-052936","line_url":"/filing/0001209191-19-052936#line-1","is_derivative":false,"issuer_cik":"0001494695","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001494695","owner_cik":"0001494695","owner_name":"Manning Paul B","owner_url":"/insider/0001494695","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5208.0,"shares_display":"5,208","price_per_share":14.02,"price_display":"14.02","price_state":"stated","total_value":73016.16,"total_display":"73,016.16","shares_owned_after":8063716.0,"shares_owned_after_display":"8,063,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-08","filed_date":"2019-10-10","scope":"insider"}],"next_cursor":"2019-10-08|7872883","ledger_fault":false,"count":{"value":82,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":72,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":82},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001819576","name":"Liquidia Corp","url":"/issuer/0001819576","role":"Director, Ten percent owner","n_filings":6,"first_seen":"2021-04-15","last_seen":"2026-06-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001841387","name":"Candel Therapeutics, Inc.","url":"/issuer/0001841387","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2021-07-29","last_seen":"2026-02-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001660334","name":"Verrica Pharmaceuticals Inc.","url":"/issuer/0001660334","role":"Director, Ten percent owner","n_filings":15,"first_seen":"2018-08-14","last_seen":"2025-11-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001806310","name":"Taysha Gene Therapies, Inc.","url":"/issuer/0001806310","role":"Director, Ten percent owner","n_filings":9,"first_seen":"2021-05-17","last_seen":"2025-06-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001576885","name":"Acumen Pharmaceuticals, Inc.","url":"/issuer/0001576885","role":"Ten percent owner","n_filings":1,"first_seen":"2021-07-08","last_seen":"2021-07-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001685071","name":"Dova Pharmaceuticals Inc.","url":"/issuer/0001685071","role":"Director, Ten percent owner","n_filings":8,"first_seen":"2017-07-07","last_seen":"2019-08-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001652923","name":"AveXis, Inc.","url":"/issuer/0001652923","role":"Director, Other","n_filings":1,"first_seen":"2016-09-15","last_seen":"2016-09-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001494695","retrieved_at":"2026-08-21T19:14:00+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}